EUVIMEDEUVIMED entdecken
Crossref

Establishing 17-Hydroxyprogesterone Cutoff Values for Congenital Adrenal Hyperplasia in Preterm, Low Birth Weight, and Sick Newborns

Young Ahn Yoon, Suhyeon Woo, Min-Sun Kim, Bohyun Kim, Young-Jin Choi

Experimental and Clinical Endocrinology & Diabetes · 01.04.2023 · 131 (04) · 216-221

DOI: 10.1055/a-2022-8399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.04.2023. Verfasst von Young Ahn Yoon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Newborn screening for congenital adrenal hyperplasia (CAH) has benefits with a high adoption rate worldwide. It also has problems of high false positives, which can cause stress to the patient’s family with economic losses and unnecessary visits of newborns to hospitals. Therefore, we investigated the influence of birth weight (BW), gestational age (GA), and GA with sampling time on 17-hydroxyprogesterone (17-OHP) concentration and attempted to establish the 17-OHP cutoff values in preterm, low birth weight (LBW), and sick newborns.

Methods

Newborns (n=1,071) born between October 2020 and January 2022 were screened for CAH. Samples from neonates were collected on filter paper with the heel prick method. 17-OHP concentration was measured by time-resolved immunofluorescence with an AutoDELFIA Neonatal 17-hydroxyprogesteron kit and grouped in relation to BW, GA, and GA with sampling time.

Results

The median age of newborns at neonatal sample collection was 6 days. 17-OHP concentration showed a statistically significant negative correlation with BW (r=−0.488, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Hyperplasia, CongenitalHumansInfant, Newborn17-alpha-HydroxyprogesteroneBirth WeightNeonatal ScreeningInfant, Low Birth Weight

Substanzen

17-alpha-Hydroxyprogesterone

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea.

Zitieren

APA

Yoon, Y. A., Woo, S., Kim, M. S., Kim, B., & Choi, Y. J. (2023). Establishing 17-Hydroxyprogesterone Cutoff Values for Congenital Adrenal Hyperplasia in Preterm, Low Birth Weight, and Sick Newborns. Experimental and Clinical Endocrinology & Diabetes, 131(04), 216-221. https://doi.org/10.1055/a-2022-8399

Vancouver

Yoon YA, Woo S, Kim MS, Kim B, Choi YJ. Establishing 17-Hydroxyprogesterone Cutoff Values for Congenital Adrenal Hyperplasia in Preterm, Low Birth Weight, and Sick Newborns. Experimental and Clinical Endocrinology & Diabetes. 2023;131(04):216-221. doi:10.1055/a-2022-8399

BibTeX
@article{Yoon2023,
  author = {Yoon, Young Ahn and Woo, Suhyeon and Kim, Min-Sun and Kim, Bohyun and Choi, Young-Jin},
  title = {Establishing 17-Hydroxyprogesterone Cutoff Values for Congenital Adrenal Hyperplasia in Preterm, Low Birth Weight, and Sick Newborns},
  journal = {Experimental and Clinical Endocrinology & Diabetes},
  year = {2023},
  volume = {131},
  number = {04},
  pages = {216--221},
  doi = {10.1055/a-2022-8399}
}
Kostenlos starten →